Cargando…

ICAM1-Targeting Theranostic Nanoparticles for Magnetic Resonance Imaging and Therapy of Triple-Negative Breast Cancer

PURPOSE: Owing to the lack of effective biomarkers, triple-negative breast cancer (TNBC) has the worst prognosis among all subtypes of breast cancer. Meanwhile, tremendous progress has been made to identify biomarkers for TNBC. However, limited number of biomarkers still restrain the specifically ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jieying, Lv, Mingchen, Su, Xiaolian, Wang, Sizhu, Wang, Yitong, Fan, Zhen, Zhang, Lin, Tang, Guangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700474/ https://www.ncbi.nlm.nih.gov/pubmed/36444196 http://dx.doi.org/10.2147/IJN.S374293

Ejemplares similares

Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics
por: Ray, Sayoni, et al.
Publicado: (2018)

PIM-1 kinase: a potential biomarker of triple-negative breast cancer
por: Chen, Jieying, et al.
Publicado: (2019)

Persistent luminescence nanoparticles for cancer theranostics application
por: Liu, Nian, et al.
Publicado: (2021)

Magnetic Nanoparticle-Based Theranostics
por: Xie, Jin, et al.
Publicado: (2012)

Magnetic Nanoparticles in Cancer Theranostics
por: Gobbo, Oliviero L., et al.
Publicado: (2015)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Magnetic nanoparticles in theranostics of malignant melanoma
por: Shevtsov, Maxim, et al.
Publicado: (2021)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Smart magnetic resonance imaging-based theranostics for cancer
por: Brito, Beatriz, et al.
Publicado: (2021)

Editorial: Advances in the Understanding of Tumor Microenvironment: Molecular and Theranostic Imaging
por: Wang, Shouju, et al.
Publicado: (2021)

Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging
por: Li, Dan, et al.
Publicado: (2014)

Theranostics Applications of Nanoparticles in Cancer Immunotherapy
por: Liu, Yihai, et al.
Publicado: (2018)

Magnetic polymeric nanoassemblies for magnetic resonance imaging-combined cancer theranostics
por: Gan, Shenglong, et al.
Publicado: (2018)

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
por: Wu, Zijun, et al.
Publicado: (2021)

Comparison of clinical and magnetic resonance imaging findings of triple-negative breast cancer with non-triple-negative tumours
por: Yetkin, Duygu İmre, et al.
Publicado: (2021)

The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics
por: Eftekhari, Aziz, et al.
Publicado: (2021)

Magnetic resonance imaging-guided and targeted theranostics of colorectal cancer
por: Li, Yanan, et al.
Publicado: (2020)

Changes in Bone Marrow Fatty Acids Early after Ovariectomy-Induced Osteoporosis in Rats and Potential Functions
por: Wang, Sizhu, et al.
Publicado: (2022)

Bone marrow fatty acids affect osteoblastic differentiation through miR-92b-3p in the early stages of postmenopausal osteoporosis
por: Wang, Sizhu, et al.
Publicado: (2023)

Cerenkov radiation-activated probes for deep cancer theranostics: a review
por: Liu, Nian, et al.
Publicado: (2022)

pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
por: Huang, Xi, et al.
Publicado: (2018)

Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia
por: Wang, Chencai, et al.
Publicado: (2017)

Gold Nanoparticles in Cancer Theranostics
por: Gao, Qinyue, et al.
Publicado: (2021)

The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer
por: Tu, Zhenbo, et al.
Publicado: (2021)

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer
por: Wen, Huang, et al.
Publicado: (2023)

Theranostic Applications of an Ultra-Sensitive T(1) and T(2) Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles
por: Mikhaylov, Georgy, et al.
Publicado: (2022)

Design of Magnetic Nanoplatforms for Cancer Theranostics
por: Jiao, Wangbo, et al.
Publicado: (2022)

Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics
por: Zhao, Shengzhe, et al.
Publicado: (2020)

Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics
por: Cerqueira, Mónica, et al.
Publicado: (2022)

Graphene-Based Magnetic Nanoparticles for Theranostics: An Overview for Their Potential in Clinical Application
por: Lage, Teresa, et al.
Publicado: (2021)

ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer
por: Chen, Mingcang, et al.
Publicado: (2022)

ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer
por: Pan, Jhih-Kai, et al.
Publicado: (2023)

Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics
por: Xie, Wensheng, et al.
Publicado: (2018)

Nitroxyl Radical as a Theranostic Contrast Agent in Magnetic Resonance Redox Imaging
por: Matsumoto, Ken-ichiro, et al.
Publicado: (2022)

Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors
por: Saha, Nandita, et al.
Publicado: (2023)

Theranostic Mesoporous Silica Nanoparticles Biodegrade after Pro-Survival Drug Delivery and Ultrasound/Magnetic Resonance Imaging of Stem Cells
por: Kempen, Paul J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d1vk4dnqtf1tegb4p3tbkc1ohb